Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment
نویسندگان
چکیده
منابع مشابه
Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment
BACKGROUND Current guidelines suggest reduction of DMARDs can be considered in RA patients in remission. Objectives were (1) to estimate the relative importance of patient characteristics rheumatologists consider in their decision to de-escalate (2) to assess whether heterogeneity exists among rheumatologists with respect to de-escalation and (3) to identify the preferred de-escalation strategy...
متن کاملUse of Biologics for Management of Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic, frequently progressive, and destructive autoimmune disease. As the disease progresses, irreversible joint damage may lead to loss of function and physical disability (World Health Organization, 2004). Patients with RA have reduced quality of life compared with healthy people. RA is associated with serious co-morbidities such as heart disease, infection, a...
متن کاملThe First Discrete Choice Experiment On Usage of Bypassing Agents in Hemophilic Patients in Iran
Background: Bleeding events in hemophilic patients with inhibitors are managed by bypassing agents. Currently available agents in Iran are recombinant activated factor VII (rfVIIa; Aryogen, Aryoseven) and Feiba (factor eight inhibitor bypassing agent). No standardized and accurate assay is currently available for monitoring the effectiveness of bypassing agents. We suggested that history of the...
متن کاملIdentifying the primary outcome for a randomised controlled trial in rheumatoid arthritis: the role of a discrete choice experiment
Background This study sought to establish the preferences of people with Rheumatoid Arthritis (RA) about the best outcome measure for a health and fitness intervention randomised controlled trial (RCT). The results of this study were used to inform the choice of the trial primary and secondary outcome measure. Methods A discrete choice experiment (DCE) was used to assess people's preferences ...
متن کاملRheumatoid arthritis: an evolutionary force in biologics.
The advent of biologic therapy has transformed the outcomes of patients with Rheumatoid Arthritis (RA), but has also highlighted important issues for their development. Early attempts at T-cell driven therapies gave mixed results with difficulties extrapolating from non-human models to first in man trials. There is currently one T-cell modulating therapy - abatacept - licenced for use in RA. Cy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Patient - Patient-Centered Outcomes Research
سال: 2021
ISSN: 1178-1653,1178-1661
DOI: 10.1007/s40271-021-00533-z